EE200300048A - Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine - Google Patents
Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamineInfo
- Publication number
- EE200300048A EE200300048A EEP200300048A EEP200300048A EE200300048A EE 200300048 A EE200300048 A EE 200300048A EE P200300048 A EEP200300048 A EE P200300048A EE P200300048 A EEP200300048 A EE P200300048A EE 200300048 A EE200300048 A EE 200300048A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- therapeutic use
- benzimidazole derivatives
- benzimidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010419A FR2812878B1 (fr) | 2000-08-08 | 2000-08-08 | Derives de benzimidazole, leur preparation et leur application en therapeutique |
FR0014696A FR2816619B1 (fr) | 2000-11-15 | 2000-11-15 | Derives de benzimidazole, leur preparation et leur application en therapeutique |
PCT/FR2001/002556 WO2002012239A1 (fr) | 2000-08-08 | 2001-08-06 | Derives de benzimidazole, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300048A true EE200300048A (et) | 2004-12-15 |
Family
ID=26212570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300048A EE200300048A (et) | 2000-08-08 | 2001-08-06 | Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine |
Country Status (28)
Country | Link |
---|---|
US (2) | US6794382B2 (no) |
EP (1) | EP1309594B1 (no) |
JP (1) | JP2004505975A (no) |
KR (1) | KR20030020450A (no) |
CN (1) | CN1446218A (no) |
AR (1) | AR030121A1 (no) |
AT (1) | ATE284886T1 (no) |
AU (1) | AU2001282267A1 (no) |
BG (1) | BG107460A (no) |
BR (1) | BR0113046A (no) |
CA (1) | CA2412368A1 (no) |
CZ (1) | CZ294493B6 (no) |
DE (1) | DE60107859T2 (no) |
EA (1) | EA005950B1 (no) |
EE (1) | EE200300048A (no) |
ES (1) | ES2233671T3 (no) |
HK (1) | HK1053118A1 (no) |
HR (1) | HRP20030081A2 (no) |
HU (1) | HUP0301514A2 (no) |
IL (1) | IL153708A0 (no) |
IS (1) | IS6661A (no) |
MX (1) | MXPA03000753A (no) |
NO (1) | NO20030596L (no) |
PL (1) | PL365080A1 (no) |
PT (1) | PT1309594E (no) |
SK (1) | SK1582003A3 (no) |
WO (1) | WO2002012239A1 (no) |
YU (1) | YU7203A (no) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
US20040014744A1 (en) * | 2002-04-05 | 2004-01-22 | Fortuna Haviv | Substituted pyridines having antiangiogenic activity |
AU2003236686A1 (en) * | 2002-06-07 | 2003-12-22 | Altana Pharma Ag | 4,5-dihydro-imidazo(4,5,1-j) quinolin-6-ones as parp inhibitors |
WO2003104233A1 (en) * | 2002-06-07 | 2003-12-18 | Altana Pharma Ag | 4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors |
WO2004108723A1 (en) * | 2003-06-04 | 2004-12-16 | Altana Pharma Ag | 4,5-dihydro-imidazo[4,5,1-ii]quinolin-6-ones as parp inhibitors |
GB0317466D0 (en) * | 2003-07-25 | 2003-08-27 | Univ Sheffield | Use |
ATE521341T1 (de) | 2003-12-01 | 2011-09-15 | Kudos Pharm Ltd | Dna-schäden-reparatur-hemmer zur behandlung von krebs |
CN101084207A (zh) * | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途 |
EP2289510A1 (en) | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
MX2007003321A (es) * | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
EP1807085B1 (en) | 2004-09-20 | 2013-08-21 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
US7547698B2 (en) * | 2004-09-20 | 2009-06-16 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD) |
US7829712B2 (en) * | 2004-09-20 | 2010-11-09 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
DE602005025924D1 (en) * | 2004-09-20 | 2011-02-24 | Xenon Pharmaceuticals Inc | Royl-coa-desaturase |
JP5094398B2 (ja) * | 2004-09-20 | 2012-12-12 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環式誘導体およびステアロイル−CoAデサチュラーゼのメディエータとしてのそれらの使用 |
AU2005329423A1 (en) * | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
EP1838306B1 (en) * | 2005-01-11 | 2010-11-17 | NeuroSearch A/S | Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
CN101208089A (zh) * | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
CA2616020A1 (en) * | 2005-08-05 | 2007-02-15 | Astrazeneca Ab | Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
WO2008003667A2 (en) * | 2006-07-03 | 2008-01-10 | Neurosearch A/S | Combinations of monoamine reuptake inhibitors and potassium channel activators |
GB0716532D0 (en) | 2007-08-24 | 2007-10-03 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
GB201220157D0 (en) * | 2012-11-08 | 2012-12-26 | Selvita Sa | Substitute tricyclic benzimidazoles as kinase inhibitors |
CN103923088B (zh) * | 2013-01-11 | 2016-09-07 | 上海汇伦生命科技有限公司 | 2,5-二氮杂双环[2.2.1]庚烷类化合物和制备方法、其药用组合物及其在医药上的应用 |
CA2903881C (en) * | 2013-03-15 | 2021-05-18 | Incyte Corporation | Tricyclic heterocycles as bet protein inhibitors |
CN104230896A (zh) | 2013-06-17 | 2014-12-24 | 上海汇伦生命科技有限公司 | 苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途 |
WO2015095492A1 (en) | 2013-12-19 | 2015-06-25 | Incyte Corporation | Tricyclic heterocycles as bet protein inhibitors |
NZ763737A (en) | 2014-04-23 | 2023-04-28 | Incyte Holdings Corp | 1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins |
US10494380B2 (en) * | 2015-05-29 | 2019-12-03 | Shionogi & Co., Ltd. | Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity |
US10189832B2 (en) | 2016-06-20 | 2019-01-29 | Incyte Corporation | Crystalline solid forms of a BET inhibitor |
CN110661676B (zh) * | 2018-06-29 | 2022-06-28 | 大唐移动通信设备有限公司 | 一种带宽部分的测量方法、配置方法、终端及网络设备 |
CN111349094B (zh) * | 2020-04-23 | 2021-02-02 | 杭州师范大学 | 一种6H-咪唑[4,5,1-ij]并喹诺酮及其合成方法和应用 |
US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2710915B1 (fr) * | 1993-10-04 | 1995-11-24 | Synthelabo | Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique. |
FR2731708B1 (fr) * | 1995-03-13 | 1997-04-30 | Synthelabo | Derives de piperidine, leur procede de preparation et leur application en therapeutique |
SK285529B6 (sk) * | 1998-11-27 | 2007-03-01 | Basf Aktiengesellschaft | Substituované benzimidazoly, farmaceutická kompozícia s ich obsahom a ich použitie ako inhibítorov PARP |
-
2001
- 2001-08-06 PL PL01365080A patent/PL365080A1/xx not_active Application Discontinuation
- 2001-08-06 JP JP2002518214A patent/JP2004505975A/ja active Pending
- 2001-08-06 SK SK158-2003A patent/SK1582003A3/sk unknown
- 2001-08-06 AT AT01960871T patent/ATE284886T1/de not_active IP Right Cessation
- 2001-08-06 EA EA200201259A patent/EA005950B1/ru not_active IP Right Cessation
- 2001-08-06 CZ CZ2003354A patent/CZ294493B6/cs not_active IP Right Cessation
- 2001-08-06 BR BR0113046-3A patent/BR0113046A/pt not_active IP Right Cessation
- 2001-08-06 CN CN01813895A patent/CN1446218A/zh active Pending
- 2001-08-06 IL IL15370801A patent/IL153708A0/xx unknown
- 2001-08-06 EE EEP200300048A patent/EE200300048A/xx unknown
- 2001-08-06 YU YU7203A patent/YU7203A/sh unknown
- 2001-08-06 EP EP01960871A patent/EP1309594B1/fr not_active Expired - Lifetime
- 2001-08-06 HU HU0301514A patent/HUP0301514A2/hu unknown
- 2001-08-06 PT PT01960871T patent/PT1309594E/pt unknown
- 2001-08-06 KR KR10-2003-7001760A patent/KR20030020450A/ko not_active Application Discontinuation
- 2001-08-06 MX MXPA03000753A patent/MXPA03000753A/es unknown
- 2001-08-06 US US10/343,467 patent/US6794382B2/en not_active Expired - Fee Related
- 2001-08-06 AU AU2001282267A patent/AU2001282267A1/en not_active Abandoned
- 2001-08-06 CA CA002412368A patent/CA2412368A1/fr not_active Abandoned
- 2001-08-06 ES ES01960871T patent/ES2233671T3/es not_active Expired - Lifetime
- 2001-08-06 AR ARP010103751A patent/AR030121A1/es not_active Application Discontinuation
- 2001-08-06 WO PCT/FR2001/002556 patent/WO2002012239A1/fr active IP Right Grant
- 2001-08-06 DE DE60107859T patent/DE60107859T2/de not_active Expired - Lifetime
-
2002
- 2002-12-19 IS IS6661A patent/IS6661A/is unknown
-
2003
- 2003-01-14 BG BG107460A patent/BG107460A/bg unknown
- 2003-02-06 NO NO20030596A patent/NO20030596L/no not_active Application Discontinuation
- 2003-02-06 HR HR20030081A patent/HRP20030081A2/hr not_active Application Discontinuation
- 2003-07-28 HK HK03105435A patent/HK1053118A1/xx not_active IP Right Cessation
-
2004
- 2004-09-13 US US10/939,910 patent/US20050032779A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2412368A1 (fr) | 2002-02-14 |
ES2233671T3 (es) | 2005-06-16 |
HRP20030081A2 (en) | 2005-02-28 |
EA005950B1 (ru) | 2005-08-25 |
JP2004505975A (ja) | 2004-02-26 |
ATE284886T1 (de) | 2005-01-15 |
CZ2003354A3 (cs) | 2003-05-14 |
AU2001282267A1 (en) | 2002-02-18 |
IS6661A (is) | 2002-12-19 |
NO20030596D0 (no) | 2003-02-06 |
PL365080A1 (en) | 2004-12-27 |
BR0113046A (pt) | 2003-07-01 |
BG107460A (bg) | 2003-09-30 |
US6794382B2 (en) | 2004-09-21 |
WO2002012239A1 (fr) | 2002-02-14 |
CZ294493B6 (cs) | 2005-01-12 |
DE60107859D1 (de) | 2005-01-20 |
IL153708A0 (en) | 2003-07-06 |
CN1446218A (zh) | 2003-10-01 |
EA200201259A1 (ru) | 2003-06-26 |
EP1309594B1 (fr) | 2004-12-15 |
NO20030596L (no) | 2003-04-01 |
HUP0301514A2 (hu) | 2003-09-29 |
MXPA03000753A (es) | 2003-10-15 |
US20030203893A1 (en) | 2003-10-30 |
SK1582003A3 (en) | 2003-08-05 |
PT1309594E (pt) | 2005-04-29 |
EP1309594A1 (fr) | 2003-05-14 |
DE60107859T2 (de) | 2005-12-22 |
YU7203A (sh) | 2006-01-16 |
AR030121A1 (es) | 2003-08-13 |
KR20030020450A (ko) | 2003-03-08 |
HK1053118A1 (en) | 2003-10-10 |
US20050032779A1 (en) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300048A (et) | Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine | |
EE04565B1 (et) | Adamantaani derivaadid, nende saamine ja kasutamine | |
EE200100470A (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
EE201300011A (et) | Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina | |
EE200100009A (et) | Bensimidasoolid, nende valmistamine ja kasutamineravimitena | |
EE200200064A (et) | Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena | |
NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
DK1177178T3 (da) | Heterocyclisk substituerede benzimidazoler, deres fremstilling og anvendelse | |
NO20021379D0 (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
EE200300193A (et) | Asendatud bensimidasoolid, nende kasutamine ja ravim | |
EE04344B1 (et) | Telmisartaani polümorfid, meetodid nende valmistamiseks ja nende kasutamine ravimi valmistamiseks | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
TR200002099A3 (tr) | Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari | |
DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
DK1043307T3 (da) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
DK1334106T3 (da) | Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf | |
FI20000818A0 (fi) | Dermatologinen käyttö ja valmiste | |
NO20024107L (no) | Tienopyridin derivater, deres fremstilling og anvendelse | |
NO20001782L (no) | 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse | |
FR2816619B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique | |
DK1309594T3 (da) | Benzimidazolderivater, fremstilling heraf og terapeutisk anvendelse heraf | |
IT1312082B1 (it) | Derivati morfinoidi, procedimento per la loro preparzione e loroimpiego terapeutico. | |
FR2816941B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique | |
FR2812878B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC1A | Change of owner name |